✦ LIBER ✦

The use of risperidone, an atypical neuroleptic, in lewy body disease

✍ Scribed by Heidi Lee; John M. Cooney; Brian A. Lawlor

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 253 KB
Volume: 9
Category: Article
ISSN: 0885-6230
DOI: 10.1002/gps.930090511

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A case of senile dementia of Lewy body type (SDLBT) who developed severe and incapacitating extrapyramidal side‐effects (EPSE) following treatment with typical neuroleptics, but responded to and tolerated the new atypical neuroleptic risperidone, is described. The potential benefits of atypical neuroleptics for elderly dementia patients with concurrent psychotic and behavioural symptoms are discussed.

📜 SIMILAR VOLUMES

Neuroleptic malignant syndrome associate

Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent

✍ Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon

The association of neuroleptic sensitivi

The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease

✍ A.W. Lemstra; N. Schoenmaker; A.J.M. Rozemuller-Kwakkel; W.A. van Gool 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Background Dementia with Lewy bodies (DLB) and Creutzfeldt‐Jakob disease (CJD) share clinical features like cognitive decline, motor disturbances en psychiatric symptoms. Overlapping symptoms may cause physicians to mistake DLB for CJD. ## Methods Clinical data of 12 patients with

The CYP2D6B mutant allele is overreprese

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease

✍ Dr. T. Saitoh; Y. Xia; X. Chen; E. Masliah; D. Galasko; C. Shults; L. J. Thal; L 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 2 views

Differentiation of dementia with Lewy bo

Differentiation of dementia with Lewy bodies from Alzheimer disease using the frontal assessment battery test

✍ Haruo Hanyu; Tomohiko Sato; Kazumasa Kume; Yusuke Takada; Takeshi Onuma; Toshihi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 2 views

Dear Editor þ p < 0.01 as compared with the DLB group. # p < 0.01 as compared with the AD group.

Risperidone in the treatment of dopamine

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

✍ Erich Mohr; Tilak Mendis; Kathleen Hildebrand; Peter Paul De Deyn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Purpose: To evaluate the safety and efficacy of risperidone in patients with parkinson's disease (pd) who are experiencing significant dopamine-induced psychosis. ## Patients and methods: Seventeen patients (median age, 72 yrs) participated in this 12-week, open pilot study receiving 0.5 to 3

Modified interphase cytogenetics techniq

Modified interphase cytogenetics technique as an adjunct in the analysis of atypical cells in body fluids

✍ Ricardo S. Cajulis; Gordon H. Yu; Sefik T. Gokaslan; Denise F. Hidvegi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Our objective was to determine the value of a modified interphase cytogenetics technique (MICT) by fluorescence in situ hybridization (FISH) in the study of atypical cells in body fluids in previously stained slides, allowing a direct morphologic-cytogenetic correlation. Thirty-five cases (29 bladde